Use of calcitonin in osteoarthritis

Details for Australian Patent Application No. 2004262906 (hide)

Owner Novartis AG Nordic Bioscience A/S

Inventors Christiansen, Claus; Bateman, Simon David; Azria, Moise; Li, Shoufeng

Agent Davies Collison Cave

Pub. Number AU-B-2004262906

PCT Pub. Number WO2005/014031

Priority 60/489,400 23.07.03 US

Filing date 22 July 2004

Wipo publication date 17 February 2005

Acceptance publication date 3 April 2008

International Classifications

A61K 38/23 (2006.01) Medicinal preparations containing peptides - Calcitonins

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 47/16 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing nitrogen

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61P 19/08 (2006.01) Drugs for skeletal disorders

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/014031 Priority application(s): WO2005/014031

3 April 2008 Application Accepted

  Published as AU-B-2004262906

31 July 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004262907-Medicament dispenser

2004262903-Combinations of a Cathepsin K inhibitor and a bisphophonate in the treatment of bone metastasis, tumor growth and tumor-induced bone loss